These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 15173176

  • 1. Caspase-2 can function upstream of bid cleavage in the TRAIL apoptosis pathway.
    Wagner KW, Engels IH, Deveraux QL.
    J Biol Chem; 2004 Aug 13; 279(33):35047-52. PubMed ID: 15173176
    [Abstract] [Full Text] [Related]

  • 2. Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells.
    Weng C, Li Y, Xu D, Shi Y, Tang H.
    J Biol Chem; 2005 Mar 18; 280(11):10491-500. PubMed ID: 15637055
    [Abstract] [Full Text] [Related]

  • 3. A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells.
    Petak I, Vernes R, Szucs KS, Anozie M, Izeradjene K, Douglas L, Tillman DM, Phillips DC, Houghton JA.
    Cell Death Differ; 2003 Jun 18; 10(6):729-39. PubMed ID: 12761581
    [Abstract] [Full Text] [Related]

  • 4. Bid mediates apoptotic synergy between tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and DNA damage.
    Broaddus VC, Dansen TB, Abayasiriwardana KS, Wilson SM, Finch AJ, Swigart LB, Hunt AE, Evan GI.
    J Biol Chem; 2005 Apr 01; 280(13):12486-93. PubMed ID: 15615731
    [Abstract] [Full Text] [Related]

  • 5. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60.
    Lamothe B, Aggarwal BB.
    J Interferon Cytokine Res; 2002 Feb 01; 22(2):269-79. PubMed ID: 11911810
    [Abstract] [Full Text] [Related]

  • 6. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis.
    Han J, Goldstein LA, Gastman BR, Rabinowich H.
    J Biol Chem; 2006 Apr 14; 281(15):10153-63. PubMed ID: 16478725
    [Abstract] [Full Text] [Related]

  • 7. Low extracellular pH augments TRAIL-induced apoptotic death through the mitochondria-mediated caspase signal transduction pathway.
    Lee YJ, Song JJ, Kim JH, Kim HR, Song YK.
    Exp Cell Res; 2004 Feb 01; 293(1):129-43. PubMed ID: 14729063
    [Abstract] [Full Text] [Related]

  • 8. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria.
    Zhang XD, Borrow JM, Zhang XY, Nguyen T, Hersey P.
    Oncogene; 2003 May 15; 22(19):2869-81. PubMed ID: 12771938
    [Abstract] [Full Text] [Related]

  • 9. Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax.
    LeBlanc H, Lawrence D, Varfolomeev E, Totpal K, Morlan J, Schow P, Fong S, Schwall R, Sinicropi D, Ashkenazi A.
    Nat Med; 2002 Mar 15; 8(3):274-81. PubMed ID: 11875499
    [Abstract] [Full Text] [Related]

  • 10. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S, Almasan A.
    Cancer Res; 2003 Aug 01; 63(15):4713-23. PubMed ID: 12907654
    [Abstract] [Full Text] [Related]

  • 11. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
    Kandasamy K, Srinivasula SM, Alnemri ES, Thompson CB, Korsmeyer SJ, Bryant JL, Srivastava RK.
    Cancer Res; 2003 Apr 01; 63(7):1712-21. PubMed ID: 12670926
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Taxol induces caspase-10-dependent apoptosis.
    Park SJ, Wu CH, Gordon JD, Zhong X, Emami A, Safa AR.
    J Biol Chem; 2004 Dec 03; 279(49):51057-67. PubMed ID: 15452117
    [Abstract] [Full Text] [Related]

  • 15. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.
    Wang S, El-Deiry WS.
    Proc Natl Acad Sci U S A; 2003 Dec 09; 100(25):15095-100. PubMed ID: 14645705
    [Abstract] [Full Text] [Related]

  • 16. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R, Bedi A.
    Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014
    [Abstract] [Full Text] [Related]

  • 17. Etoposide upregulates Bax-enhancing tumour necrosis factor-related apoptosis inducing ligand-mediated apoptosis in the human hepatocellular carcinoma cell line QGY-7703.
    Miao L, Yi P, Wang Y, Wu M.
    Eur J Biochem; 2003 Jul 01; 270(13):2721-31. PubMed ID: 12823542
    [Abstract] [Full Text] [Related]

  • 18. Trail-induced apoptosis in Type I leukemic cells is not enhanced by overexpression of bax.
    Jia L, Patwari Y, Kelsey SM, Newland AC.
    Biochem Biophys Res Commun; 2001 May 25; 283(5):1037-45. PubMed ID: 11355877
    [Abstract] [Full Text] [Related]

  • 19. Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax.
    Werner AB, de Vries E, Tait SW, Bontjer I, Borst J.
    J Biol Chem; 2002 Jun 21; 277(25):22781-8. PubMed ID: 11929871
    [Abstract] [Full Text] [Related]

  • 20. Stimulation of the mitogen-activated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells.
    Sarker M, Ruiz-Ruiz C, Robledo G, López-Rivas A.
    Oncogene; 2002 Jun 20; 21(27):4323-7. PubMed ID: 12082620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.